Nephrology in North Las Vegas, NV
5 verified nephrology doctors in North Las Vegas.
Nephrologists treat kidney disease, high blood pressure, and disorders of fluid and electrolyte balance.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Nevada State Board of Medical Examiners
Dr. Marina Antar-Shultz, DO
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Beata Jasiurkowski, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Milen Amde, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Elias Ugwu, MD
Nephrology
CMS Open Payments· $3,150 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,150
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 10,935 nephrology doctors we've analyzed, about 59% received any industry payment (median $286 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US nephrology doctors.
Payments to Elias Ugwu do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Cameron Charlow, DO
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.